Related Experiment Video
Updated: Jul 18, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
[Correlation between plasma level of homocysteine and cerebral large-artery atherosclerosis]
Gui-hong Wang1, Yong-jun Wang, Yao He
1Department of Neurology, Beijing Tiantan Hospital, Capital University of Medical Science, Beijing 100050, China. guihongw@126.com
Insights
High plasma homocysteine is an independent risk factor for cerebral large-artery atherosclerosis in ischemic stroke patients. This risk is amplified by hypertension, older age, and low HDL cholesterol levels.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Clinical Biochemistry
Background:
- Ischemic stroke is a leading cause of disability and mortality worldwide.
- Cerebral large-artery atherosclerosis is a major contributor to ischemic stroke.
- Identifying modifiable risk factors is crucial for stroke prevention.
Purpose of the Study:
- To determine if elevated plasma homocysteine is an independent risk factor for cerebral large-artery atherosclerotic stenosis.
- To assess the association between homocysteine levels and stroke severity.
- To investigate the interaction of homocysteine with conventional risk factors.
Main Methods:
- A cohort of 276 adult ischemic stroke patients undergoing digital subtraction angiography (DSA) was studied.
- Patients were categorized into those with significant large-artery stenosis (>50%) and controls.
- Plasma homocysteine levels and conventional stroke risk factors were analyzed.
Main Results:
- High plasma homocysteine (>15 micromol/L) was significantly more prevalent in patients with atherosclerotic stenosis (38.8% vs. 15.4%).
- Multivariable analysis confirmed homocysteine as an independent risk factor (OR 4.10, P=0.001).
- The association was stronger with hypertension (OR 4.89), older age (OR 4.79), and low HDL (OR 10.46).
Conclusions:
- Elevated plasma homocysteine is an independent risk factor for cerebral large-artery atherosclerosis.
- The impact of homocysteine on stroke risk is potentiated by the presence of other risk factors like hypertension and dyslipidemia.
Objective:
To identify whether high level of plasma homocysteine is an independent risk factor for potential cerebral large-artery atherosclerotic stenosis determined by digital subtraction angiography (DSA) in patients with ischemic stroke.
Methods:
276 adult patients with ischemic stroke experienced DSA were selected, and 224 patients with potential large-artery atherosclerotic stenosis (grade > 50%, not less than one of vascular) and 52 controls without stenosis or mild grade (grade < or = 50%) were included. Plasma homocysteine level was analyzed and conventional risk factors of cerebral stroke such as sex and age, hypertension, diabetes, long-smoking, long-alcohol and plasma levels of triglyceride, high-density lipoprotein, low-density lipoprotein was evaluated in 276 subjects.
Results:
The proportion of subjects with high level of plasma homocysteine (> 15 micromol/L) was significantly higher in patients with potential atherosclerotic stenosis than those without (38.8% versus 15.4%; OR 3.49, 95% CI 1.57 - 7.77, P = 0.001). Based on multivariable stepwise logistic regression model, the odds ratio of homocysteine levels was 4.10 (95% CI 1.80 - 9.32, P = 0.001) with additional adjustment for conventional risk factors. The effect of homocysteine was more pronounced in the presence of hypertension (OR = 4.89), old age (OR = 4.79) and low level of plasma high density lipoprotein (OR = 10.46).
Conclusions:
It is suggested that high level of plasma homocysteine is an independent risk factor for cerebral large-artery atherosclerosis. The effect of homocysteine is more pronounced in the presence of other risk factors of ischemic stroke.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
